Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 6 de 6
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
Eur J Heart Fail ; 9(12): 1163-71, 2007 Dec.
Artigo em Inglês | MEDLINE | ID: mdl-17999941

RESUMO

OBJECTIVE: To analyze the implication of the beta3-adrenoceptor (beta3-AR) pathway in human septic myocardium and a murine model of sepsis, a condition associated with myocardial depression. METHODS AND RESULTS: beta3-AR and eNOS protein abundance were increased (332+/-66.4% and 218+/-39.3; P<0.05) in hearts from septic patients. The effect of BRL37344, a beta3-AR-preferential agonist, was analyzed by videomicroscopy on the contractility of neonatal mouse ventricular myocytes (NMVM) incubated with conditioned medium from LPS-stimulated cultured macrophages (Mc-LPS+ medium). Stimulation of untreated NMVM with BRL37344 dose-dependently decreased the amplitude of contractile shortening (P<0.05). This response was abolished by L-NAME (NOS inhibitor). Incubation in Mc-LPS+ medium potentiated the depressing effect of BRL37344 (P<0.05) as well as of SR58611A (P<0.05) in wild-type myocytes. Importantly, the contractile depression was abrogated in cardiomyocytes from beta3-AR KO mice. CONCLUSIONS: beta3-AR are upregulated during sepsis in the human myocardium and by cytokines in murine cardiomyocytes, where they mediate an increased negative inotropic response to beta3 agonists. Activation of the beta3-AR pathway by catecholamines may contribute to the myocardial dysfunction in sepsis.


Assuntos
Miócitos Cardíacos/metabolismo , RNA/genética , Receptores Adrenérgicos beta 3/genética , Sepse/metabolismo , Regulação para Cima , Agonistas de Receptores Adrenérgicos beta 3 , Agonistas Adrenérgicos beta/farmacologia , Adulto , Animais , Animais Recém-Nascidos , Western Blotting , Células Cultivadas , Meios de Cultivo Condicionados/farmacologia , Modelos Animais de Doenças , Etanolaminas/farmacologia , Humanos , Masculino , Camundongos , Camundongos Endogâmicos C57BL , Pessoa de Meia-Idade , Contração Miocárdica/efeitos dos fármacos , Contração Miocárdica/fisiologia , Miócitos Cardíacos/efeitos dos fármacos , Miócitos Cardíacos/patologia , RNA/biossíntese , Ratos , Ratos Wistar , Receptores Adrenérgicos beta 3/biossíntese , Reação em Cadeia da Polimerase Via Transcriptase Reversa , Sepse/patologia , Sepse/fisiopatologia , Estereoisomerismo
2.
EMBO J ; 18(22): 6396-406, 1999 Nov 15.
Artigo em Inglês | MEDLINE | ID: mdl-10562551

RESUMO

The locus control region (LCR) of the human CD2 gene (hCD2) confers T cell-specific, copy-dependent and position-independent gene expression in transgenic mice. This LCR consists of a strong T cell-specific enhancer and an element without enhancer activity (designated HSS3), which is required for prevention of position effect variegation (PEV) in transgenic mice. Here, we identified the HMG box containing protein-1 (HBP1) as a factor binding to HSS3 of the hCD2 LCR. Within the LCR, HBP1 binds to a novel TTCATTCATTCA sequence that is higher in affinity than other recently reported HBP1-binding sites. Mice transgenic for a hCD2 LCR construct carrying a deletion of the HBP1-binding sequences show a propensity for PEV if the transgene integrates in a heterochromatic region of the chromosome such as the centromere or telomere. We propose that HBP1 plays an important role in chromatin opening and remodelling activities by binding to and bending the DNA, thus allowing DNA-protein and/or protein-protein interactions, which increase the probability of establishing an active locus.


Assuntos
Antígenos CD2/genética , Proteínas de Grupo de Alta Mobilidade/genética , Proteínas de Grupo de Alta Mobilidade/metabolismo , Região de Controle de Locus Gênico , Proteínas Repressoras/genética , Proteínas Repressoras/metabolismo , Sequência de Aminoácidos , Animais , Sequência de Bases , Sítios de Ligação , Antígenos CD2/biossíntese , Clonagem Molecular , Impressões Digitais de DNA , Desoxirribonuclease I , Escherichia coli/genética , Proteínas de Grupo de Alta Mobilidade/química , Humanos , Camundongos , Camundongos Transgênicos , Dados de Sequência Molecular , Proteínas Nucleares/metabolismo , Proteínas Repressoras/química , Mapeamento por Restrição , Deleção de Sequência , Linfócitos T/imunologia
3.
Mol Cell Endocrinol ; 152(1-2): 111-23, 1999 Jun 25.
Artigo em Inglês | MEDLINE | ID: mdl-10432229

RESUMO

Expression of the tilapia growth hormone (tiGH) gene is pituitary-specific and controlled by intracellular cAMP levels. DNaseI protection experiments allowed us to identify four Pit-1 binding sites in the tiGH - 465/ + 19 region. Deletion and mutagenesis analysis revealed that the - 131/+ 19 region, containing two Pit-1 sites, or four copies of the most proximal site tiGHF1 fused to the heterologous Tk promoter, confer high level expression in rat pituitary cells and direct transcription in non-pituitary cells only after expression of rat Pit-1. We show that a tilapia pituitary factor specifically binds to site tiGHF1 and obtained a partial cDNA sequence coding for tilapia Pit-1. The cAMP stimulation is mediated by the proximal (- 131/- 31) promoter region. It is Pit-1-dependent and requires the tiGHF1 site. In addition, four copies of this site confer cAMP inducibility to the Tk promoter in GC cells.


Assuntos
AMP Cíclico/farmacologia , Proteínas de Ligação a DNA/genética , Regulação da Expressão Gênica/efeitos dos fármacos , Hormônio do Crescimento/genética , Tilápia/genética , Fatores de Transcrição/genética , Sequência de Aminoácidos , Animais , Sequência de Bases , Proteínas de Ligação a DNA/metabolismo , Hormônio do Crescimento/metabolismo , Dados de Sequência Molecular , Regiões Promotoras Genéticas/genética , Ratos , Alinhamento de Sequência , Fator de Transcrição Pit-1 , Fatores de Transcrição/metabolismo , Transcrição Gênica/efeitos dos fármacos
4.
DNA Cell Biol ; 18(6): 489-502, 1999 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-10390158

RESUMO

A gene encoding the Tilapia mossambica (Oreochromis mossambicus) growth hormone (tiGH) was isolated and sequenced. The gene spans 5.6 kb, including 3.7 kb of 5' and 0.2 kb of 3' flanking sequences and a 1.7-kb transcription unit comprised of six exons and five introns. The gene and the 5' flanking region contain several potential binding sites for Pit-1, a key transcription activator of mammalian GH genes. One of these (-57/-42) is highly conserved in fish GH genes. It activates transcription in pituitary cells and binds Pit-1. Transfection of luciferase reporter plasmids containing either the -3602/+19 tiGH sequence or one of its 5' deletion mutants (-2863/, -1292/, and -463/+19) resulted in strong activity in Pit-1-producing rat pituitary GC cells. A dose-dependent activation of the tiGH promoter was achieved in nonpituitary fish EPC and monkey COS cells cotransfected with a rat Pit-1 expression vector, demonstrating the crucial role played by Pit-1 as an activator of the tiGH gene. Fusion of the tiGH promoter with the beta-galactosidase gene led to transient expression specifically in the nervous system of microinjected zebrafish embryos. The activity of the tiGH promoter in GC and EPC cells was strongly repressed by extending its 3' end from +19 to +40, a sequence in which a Pit-1-binding site was identified using gel retardation assays. Point mutations of the site that suppressed Pit-1 binding in vitro restored full tiGH promoter activity. Thus, a Pit-1-binding site located in the 5' untranslated region mediates Pit-1-dependent repression of the tiGH gene.


Assuntos
Proteínas de Ligação a DNA/fisiologia , Hormônio do Crescimento/genética , Proteínas Repressoras/fisiologia , Tilápia/genética , Fatores de Transcrição/fisiologia , Ativação Transcricional , Regiões 3' não Traduzidas/química , Regiões 5' não Traduzidas/química , Sequência de Aminoácidos , Animais , Sequência de Bases , Sítios de Ligação/genética , Clonagem Molecular , Proteínas de Ligação a DNA/biossíntese , Proteínas de Ligação a DNA/metabolismo , Hormônio do Crescimento/antagonistas & inibidores , Hormônio do Crescimento/isolamento & purificação , Hormônio do Crescimento/metabolismo , Dados de Sequência Molecular , Sistema Nervoso/embriologia , Sistema Nervoso/metabolismo , Oncorhynchus mykiss , Neoplasias Hipofisárias , Regiões Promotoras Genéticas/genética , Ratos , Proteínas Recombinantes de Fusão/genética , Proteínas Repressoras/biossíntese , Proteínas Repressoras/metabolismo , Análise de Sequência de DNA , Fator de Transcrição Pit-1 , Fatores de Transcrição/biossíntese , Fatores de Transcrição/metabolismo , Células Tumorais Cultivadas , Peixe-Zebra/embriologia
5.
Mol Mar Biol Biotechnol ; 3(2): 57-69, 1994 Apr.
Artigo em Inglês | MEDLINE | ID: mdl-8087184

RESUMO

The transfer of exogenous DNA in fish represents a powerful strategy to study the regulation of gene expression in vivo. The African catfish (Clarias gariepinus) was chosen for this study because of its scientific and economic importance due to its easy husbandry, its short developmental period, and its value as a protein source in Africa and Asia. Fertilized eggs (1- and 2-cell stage) were cytoplasmatically injected with either supercoiled or linearized plasmids harboring the fusion genes encoding beta-galactosidase (lacZ) or luciferase (Luc) without a promoter or fused to the promoter/enhancer of human cytomegalovirus (CMV). Replication of the exogenous DNA peaked at 4 hours (early gastrula) and again at 2 days (which corresponds to the developmental stage of yolksac resorption). Foreign DNA persisted during embryogenesis, and it was still detectable 8 months after injection. In vivo transient expression of both CMV fusion genes was mosaic and peaked within 24 hours after DNA injection. Transient expression of the luciferase reporter gene could be detected with a much higher sensitivity than the lacZ gene. These data establish African catfish as a suitable in vivo assay system, and they confirm the luciferase reporter gene as a high quality reporter gene in fish.


Assuntos
Peixes-Gato/genética , Replicação do DNA , DNA Recombinante/genética , Animais , Animais Geneticamente Modificados , Sequência de Bases , Southern Blotting , Peixes-Gato/embriologia , Técnicas de Cultura , Primers do DNA , Feminino , Técnicas de Transferência de Genes , Larva/metabolismo , Masculino , Microinjeções , Dados de Sequência Molecular
6.
DNA Cell Biol ; 11(9): 673-84, 1992 Nov.
Artigo em Inglês | MEDLINE | ID: mdl-1418624

RESUMO

The tilapia (Oreochromis mossambicus) prolactin-I (PRL-I) gene has been cloned and sequenced. Its transcript (3,677 bases long) begins with a guanine and is organized in five exons and four introns like the other known prolactin genes. Analysis of the 1,555-bp 5'-flanking region suggests that pituitary-specific expression of the gene could be regulated through a trans-factor related to the mammalian pituitary-specific factor Pit-1. Two potential binding sites for such a factor were found in the first intron, suggesting a possible regulatory role for this region. Moreover, two potential Z-DNA regions are located at positions -837 to -812 and -246 to -179 from the transcription start site. These two regions could play an important role in the regulation of PRL gene expression.


Assuntos
Prolactina/genética , Sequência de Aminoácidos , Animais , Sequência de Bases , Southern Blotting , Clonagem Molecular , DNA , Humanos , Dados de Sequência Molecular , Mapeamento por Restrição , Homologia de Sequência de Aminoácidos , Tilápia , Transcrição Gênica
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...